“Post-transplant infections now exceed acute rejection as cause for hospitalization: a report of the NAPRTCS”, Am J Transplant, vol. 4, pp. 384-9, 2004.,
“Posttransplant survival in pediatric fulminant hepatic failure: the SPLIT experience”, Liver Transplantation, vol. 10, pp. 1364-1371, 2004.,
“Predictors of length of stay for pediatric liver transplant recipients”, Liver Transpl, vol. 10, pp. 1011-7, 2004.,
“Predictors of length of stay for pediatric liver transplant recipients”, Liver Transplantation, vol. 10, pp. 1011-1017, 2004.,
“Pretransplant recipient cytomegalovirus seropositivity and hemodialysis are associated with decreased renal allograft and patient survival”, Transplantation, vol. 77, pp. 1405-1411, 2004.,
“Priming with a Candidate HIV-1 Clade A DNA Vaccine Followed by Boosting with an HIV-1 Clade A MVA Vaccine in Volunteers at Low risk of HIV Infection”, in AIDS Vaccine 2004 International Conference, Lausanne, Switzerland, 2004.,
“A Prospective, Randomized, Trial of the Effect of Multi-Center Trial of Antibody Induction in Simultaneous Pancreas and Kidney Transplantation: Three Year Results”, American Journal of Transplantation, vol. 77, no. 8, pp. 1269-1275, 2004.,
“Palivizumab prophylaxis of respiratory syncytial virus (RSV) - results from the 2000-2001 Synagis Outcomes Registry”, Pediatr Pulmonol, vol. 35, pp. 484-9, 2003.
“Palivizumab prophylaxis of RSV disease: demographic and risk factors results from the 2002-2003 Outcomes Registry”, J Perinatology, vol. 23, p. 592, 2003.,
“Patterns of RSV Disease Prophylaxis in Infants with Congenital Heart Disease (CHD): Preliminary Results From the 2002-2003 Palivizumab Outcomes Registry”, J Perinatology, vol. 23, p. 594, 2003.,
“Potential public health impact of Age-Related Eye Disease Study results. AREDS Report No.11”, Arch Ophthalmol, vol. 121, pp. 1621-1624, 2003.
“Predicting Hepatitis B Virus-Positive Metastatic Hepatocellular Carcinomas Using Gene Expression Profiling and Supervised Machine Learning”, Nat Med, vol. 9, no. 4, pp. 416-423, 2003.,
“Prograf as Secondary Intervention vs Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft Failure (CRAF) Results in Improved Renal Function, Decreased CV Risk, and No Increased Risk for Diabetes”, 2003.
“Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation: A grading algorithm versus blinded expert panel review”, Biol Blood Marrow Transplant, vol. 9, pp. 512-8, 2003.,
“A Prospective, Randomized, Double Blind, Multicenter Trial of Early (7 Day) Corticosteroid Cessation vs Long Term Low Dose Corticosteroid Therapy Under Tacrolimus and Mycopheonlate Mofetil Therapy with Antibody Induction”, in American Transplant Congress (ATC), 2003.,
“A prospective, randomized, multi-center trial of antibody induction therapy in simultaneous pancreas-kidney transplantation”, American Journal of Transplantation, vol. 3, pp. 855-64, 2003.
“Psychometric properties of the National Eye Institute - Refractive Error Quality of Life (NEI-RQL) instrument”, Ophthalmology, vol. 110, pp. 2292-2301, 2003.,
“Pretransplant peritoneal dialysis and graft thrombosis following pediatric kidney transplantation: a NAPRTCS report”, Pediatr Transplantation, vol. 7, pp. 204-8, 2002.,
“Prospective Grading of Graft-Versus-Host Disease After Unrelated Donor Marrow Transplantation: a Grading Algorithm Versus Blinded Expert Panel Review”, Biol Blood Marrow Transplant, vol. 9, no. 8, pp. 512-518, 2002.,
“Post-transplant diabetes mellitus in pediatric renal transplant recipients: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)”, Transplantation, vol. 72, pp. 1020-4, 2001.,
“Pretransplant inflammation and renal allograft survival: The role of recipient cytomegalovirus (CMV) serostatus and dialysis modality”, 2001.,
“Proceedings of the 2nd International Congress on Immunosuppression”, in International Congress on Immunosuppression, San Diego, California, 2001.,
“A Program Designed to Provide and Maintain Training in a Large Long-Term Clinical Trial”, Control Clin Trials, vol. 22, p. 865, 2001.,
“A Phase II Study of Two HIV-1 Envelope Vaccines Comparing their Immunogenicity in Populations at Risk for Acquiring HIV-1 Infection”, AIDS Res HumRetroviruses, vol. 16, pp. 907-19, 2000.,